0.000USD0.000Pre-market 07/24, 09:30 (ET)
208.17MMarket Cap
LossP/E TTM
Orchestra Biomed Holdings Inc
Key Figures
3.590Open
3.750High
161.41KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.28%Turnover Ratio
3.630Prev. Close
3.555Low
407.64KTurnover
LossP/E Static
3.89P/B
0.00%Div Yield TTM
-68.33%ROA
5.42452wk High
0.82Volume Ratio
-61.02MNet Profit
57.03MShares
-0.9479EPS TTM
0.51Beta
-189.00%ROE
2.20052wk Low
5.37%Amplitude
70.91%Gross Margin
208.17MMarket Cap
-2.11Reward/Risk
4.17%Risk Rate
Currency: USD Updated: 2026-07-23 Key Insights
Orchestra Biomed Holdings Inc's fundamentals are relatively healthy, and its growth potential is good.Its valuation is considered fairly valued, ranking 115 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.17.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Orchestra Biomed Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Orchestra Biomed Holdings Inc Highlights
StrengthsRisks
Orchestra Biomed Holdings Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Orchestra Biomed Holdings Inc
OBIO
7
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Orchestra Biomed Holdings Inc Info
Orchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.
Ticker SymbolOBIO
CompanyOrchestra Biomed Holdings Inc
CEOHochman (David P)
Website
Shareholders
FAQs
What is the current price of Orchestra Biomed Holdings Inc (OBIO)?
The current price of Orchestra Biomed Holdings Inc (OBIO) is 3.65.
What is the symbol of Orchestra Biomed Holdings Inc?
The ticker symbol of Orchestra Biomed Holdings Inc is OBIO.
What is the 52-week high of Orchestra Biomed Holdings Inc?
The 52-week high of Orchestra Biomed Holdings Inc is 5.42.
What is the 52-week low of Orchestra Biomed Holdings Inc?
The 52-week low of Orchestra Biomed Holdings Inc is 2.20.
What is the market capitalization of Orchestra Biomed Holdings Inc?
The market capitalization of Orchestra Biomed Holdings Inc is 208.17M.
Is Orchestra Biomed Holdings Inc (OBIO) currently rated as Buy, Hold, or Sell?
According to analysts, Orchestra Biomed Holdings Inc (OBIO) has an overall rating of Buy, with a price target of 12.17.
What is the Earnings Per Share (EPS TTM) of Orchestra Biomed Holdings Inc (OBIO)?
The Earnings Per Share (EPS TTM) of Orchestra Biomed Holdings Inc (OBIO) is -1.11.
